1. Home
  2. SCLX vs LITB Comparison

SCLX vs LITB Comparison

Compare SCLX & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • LITB
  • Stock Information
  • Founded
  • SCLX 2011
  • LITB 2007
  • Country
  • SCLX United States
  • LITB Singapore
  • Employees
  • SCLX N/A
  • LITB N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • SCLX Health Care
  • LITB Consumer Discretionary
  • Exchange
  • SCLX Nasdaq
  • LITB Nasdaq
  • Market Cap
  • SCLX 33.9M
  • LITB 32.7M
  • IPO Year
  • SCLX N/A
  • LITB N/A
  • Fundamental
  • Price
  • SCLX $5.70
  • LITB $1.12
  • Analyst Decision
  • SCLX Strong Buy
  • LITB
  • Analyst Count
  • SCLX 3
  • LITB 0
  • Target Price
  • SCLX $367.50
  • LITB N/A
  • AVG Volume (30 Days)
  • SCLX 125.0K
  • LITB 9.0K
  • Earning Date
  • SCLX 08-12-2025
  • LITB 08-01-2025
  • Dividend Yield
  • SCLX N/A
  • LITB N/A
  • EPS Growth
  • SCLX N/A
  • LITB N/A
  • EPS
  • SCLX N/A
  • LITB 0.08
  • Revenue
  • SCLX $50,710,000.00
  • LITB $231,136,000.00
  • Revenue This Year
  • SCLX $107.00
  • LITB N/A
  • Revenue Next Year
  • SCLX $82.52
  • LITB N/A
  • P/E Ratio
  • SCLX N/A
  • LITB $14.02
  • Revenue Growth
  • SCLX 7.79
  • LITB N/A
  • 52 Week Low
  • SCLX $3.60
  • LITB $0.91
  • 52 Week High
  • SCLX $78.05
  • LITB $5.70
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 49.86
  • LITB 42.59
  • Support Level
  • SCLX $4.53
  • LITB $1.07
  • Resistance Level
  • SCLX $5.60
  • LITB $1.21
  • Average True Range (ATR)
  • SCLX 0.41
  • LITB 0.08
  • MACD
  • SCLX 0.01
  • LITB -0.00
  • Stochastic Oscillator
  • SCLX 31.96
  • LITB 24.00

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: